Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abbott launches Biothreat assay for Plex-ID system
The assay allows rapid and accurate detection of microorganisms that cause serious threats to human health, food, water and other resources. The Plex-ID Biothreat assay analyses direct specimens,
The assay allows rapid and accurate detection of microorganisms that cause serious threats to human health, food, water and other resources. The Plex-ID Biothreat assay analyses direct specimens,
As many hormones exist in extremely low abundance, ARUP turned to QTRAP technology to obtain a higher level of sensitivity, which is needed to perform the most accurate
AN2728 is a boron-based small-molecule compound which inhibits the activity of phosphodiesterase-4 (PDE4), thereby reducing the generation of pro-inflammatory cytokines that are the precursors of the inflammation associated
Makena, sponsored by US-based Hologic, is indicated for pregnant women with a history of at least one spontaneous preterm birth. The drug is not intended for women with
Synexus announced its plans to be involved in ophthalmology trials last October after discussions with leading sponsors. The trial will be conducted on behalf of a pharmaceutical company
INT0022 has been developed using IntelGenx’ proprietary immediate release ‘VersaFilm’ drug delivery technology The randomised, two-period, two-way crossover study in healthy male subjects was designed to evaluate whether
In the study, Inovio researchers investigated whether the electrical field strength generated by piezoelectricity alone could elicit gene transfer in the skin of an animal. Researchers injected a
The Wiley Protocol, the brainchild of Wiley, is a trademarked, patent-protected, bio-identical hormone replacement therapy (HRT) delivery system consisting of biomimetic estradiol and progesterone in a topical cream
The Zolpimist Oral Spray unit contains 60 metered sprays and provides the flexibility of administering either a 5 or 10 mg dose of the zolpidem active ingredient, ECR
17P will now be marketed under the brand name Makena and given in weekly injections to pregnant women between 16 and 20 weeks gestation, continuing until 37 weeks